BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36107559)

  • 61. Gastroesophageal reflux disease during pregnancy.
    Richter JE
    Gastroenterol Clin North Am; 2003 Mar; 32(1):235-61. PubMed ID: 12635418
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
    Cohen S; Bueno de Mesquita M; Mimouni FB
    Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ABC of the upper gastrointestinal tract: Oesophagus: heartburn.
    de Caestecker J
    BMJ; 2001 Sep; 323(7315):736-9. PubMed ID: 11576983
    [No Abstract]   [Full Text] [Related]  

  • 64. Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.
    Green DS; Abdel-Latif ME; Jones LJ; Lui K; Osborn DA
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011785. PubMed ID: 31265739
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease.
    Takenaka R; Okada H; Kawano S; Komazawa Y; Yoshinaga F; Nagata S; Inoue M; Komatsu H; Onogawa S; Kushiyama Y; Mukai S; Todo H; Okanobu H; Manabe N; Tanaka S; Haruma K; Kinoshita Y
    World J Gastroenterol; 2016 Jun; 22(23):5430-5. PubMed ID: 27340360
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Medical therapy for gastroesophageal reflux disease.
    Arora AS; Castell DO
    Mayo Clin Proc; 2001 Jan; 76(1):102-6. PubMed ID: 11155401
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Drugs, bugs, and esophageal pH profiles.
    Robinson M
    Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies.
    Tran T; Lowry AM; El-Serag HB
    Aliment Pharmacol Ther; 2007 Jan; 25(2):143-53. PubMed ID: 17229239
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.
    Lin BM; Curhan SG; Wang M; Jacobson BC; Eavey R; Stankovic KM; Curhan GC
    Ear Hear; 2017; 38(1):21-27. PubMed ID: 27556519
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.
    Bhatia SJ; Makharia GK; Abraham P; Bhat N; Kumar A; Reddy DN; Ghoshal UC; Ahuja V; Rao GV; Devadas K; Dutta AK; Jain A; Kedia S; Dama R; Kalapala R; Alvares JF; Dadhich S; Dixit VK; Goenka MK; Goswami BD; Issar SK; Leelakrishnan V; Mallath MK; Mathew P; Mathew P; Nandwani S; Pai CG; Peter L; Prasad AVS; Singh D; Sodhi JS; Sud R; Venkataraman J; Midha V; Bapaye A; Dutta U; Jain AK; Kochhar R; Puri AS; Singh SP; Shimpi L; Sood A; Wadhwa RT
    Indian J Gastroenterol; 2019 Oct; 38(5):411-440. PubMed ID: 31802441
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Medical treatments of GERD: the old and new.
    Vela MF
    Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy.
    Papasavas PK; Keenan RJ; Yeaney WW; Caushaj PF; Gagné DJ; Landreneau RJ
    Surg Endosc; 2003 Aug; 17(8):1200-5. PubMed ID: 12739117
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gastroesophageal reflux disease prevalence in the city of Sivas.
    Yönem Ö; Sivri B; Özdemir L; Nadir I; Yüksel S; Uygun Y
    Turk J Gastroenterol; 2013; 24(4):303-10. PubMed ID: 24254260
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease.
    Thomson RM; Armstrong JG; Looke DF
    Chest; 2007 Apr; 131(4):1166-72. PubMed ID: 17426224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Profile and assessment of GERD pharmacotherapy.
    Maton PN
    Cleve Clin J Med; 2003 Nov; 70 Suppl 5():S51-70. PubMed ID: 14705381
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease.
    Ivashkin VT; Maev IV; Trukhmanov AS; Rumyantseva DE
    Ter Arkh; 2018 Aug; 90(8):4-12. PubMed ID: 30701934
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
    J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and safety of histamine-2 receptor antagonists.
    van der Pol R; Langendam M; Benninga M; van Wijk M; Tabbers M
    JAMA Pediatr; 2014 Oct; 168(10):947-54. PubMed ID: 25133940
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].
    Poen AC; Otten MH
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1632-6. PubMed ID: 12966628
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
    van Zanten SV
    Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.